HCV Drug Resistance Testing

HCV Drug Resistance Testing

Monogram has leveraged its expertise in phenotypic and genotypic drug resistance testing to develop a comprehensive platform of drug resistance tests for the new hepatitis C direct-acting antivirals (DAAs), including Q80K polymorphism screening. Please contact Monogram regarding technical and pricing information and validation summaries for the following assays:

  • Sequencing and phenotype testing
  • NS5B
  • NS3/4A
  • NS5A, for both genotypes 1a/b and 3
  • Clone isolation and analyses
  • Resistance characterization against virus panels
  • Deep/next-generation viral sequencing 

Download a sample report for: